{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:56:52Z","timestamp":1789102612159,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.mce.2021.111263","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T11:43:47Z","timestamp":1617191027000},"page":"111263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Effect of ramipril on kidney, lung and heart ACE2 in a diabetic mice model"],"prefix":"10.1016","volume":"529","author":[{"given":"Ander","family":"Vergara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conxita","family":"Jacobs-Cach\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Molina-Van den Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Dom\u00ednguez-B\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Garc\u00eda-Carro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ser\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mce.2021.111263_bib1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/joim.13101","article-title":"COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - is there any scientific evidence for controversy?","volume":"288","author":"Aleksova","year":"2020","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.mce.2021.111263_bib2","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2337\/db20-0765","article-title":"Lung and kidney ACE2 and TMPRSS2 in renin angiotensin system blocker treated comorbid diabetic mice mimicking host factors that have been linked to severe COVID-19","volume":"70","author":"Batchu","year":"2020","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.mce.2021.111263_bib3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1042\/CS20200163","article-title":"Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?","volume":"134","author":"Batlle","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"issue":"6","key":"10.1016\/j.mce.2021.111263_bib4","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/ki.2011.381","article-title":"Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy","volume":"81","author":"Batlle","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.mce.2021.111263_bib5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1042\/CS20120162","article-title":"Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions","volume":"123","author":"Burchill","year":"2012","journal-title":"Clin. Sci."},{"key":"10.1016\/j.mce.2021.111263_bib6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehi114","article-title":"Myocardial infarction increases ACE2 expression in rat and humans","volume":"26","author":"Burrell","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.mce.2021.111263_bib7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.virol.2006.06.011","article-title":"Interferon-\u03b3 and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells","volume":"353","author":"de Lang","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.mce.2021.111263_bib8","article-title":"Antihypertensive medication uses and serum ACE2 levels: ACEIs\/ARBs treatment does not raise serum levels of ACE2","author":"Emilsson","year":"2020","journal-title":"medRxiv Prepr. Serv. Heal. Sci."},{"issue":"6","key":"10.1016\/j.mce.2021.111263_bib9","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s40618-020-01236-2","article-title":"Prevalence and impact of diabetes among people infected with SARS-CoV-2","volume":"43","author":"Fadini","year":"2020","journal-title":"J. Endocrinol. Invest."},{"issue":"9210","key":"10.1016\/j.mce.2021.111263_bib10","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(05)72259-5","article-title":"The HOPE study and diabetes. Heart outcomes prevention evaluation","volume":"355","author":"Fegan","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.mce.2021.111263_bib11","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2021.111263_bib12","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/jcm8060864","article-title":"The new era for reno-cardiovascular treatment in type 2 diabetes","volume":"8","author":"Garc\u00eda-Carro","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.mce.2021.111263_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-2-19","article-title":"ACE2 gene expression is up-regulated in the human failing heart","volume":"2","author":"Goulter","year":"2004","journal-title":"BMC Med."},{"key":"10.1016\/j.mce.2021.111263_bib14","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.mce.2021.111263_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.mce.2021.111263_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00004872-199303000-00012","article-title":"I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications","volume":"11","year":"1993","journal-title":"J. Hypertens."},{"key":"10.1016\/j.mce.2021.111263_bib17","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","article-title":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors","volume":"43","author":"Ishiyama","year":"2004","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.mce.2021.111263_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.coph.2006.03.001","article-title":"Angiotensin-converting enzyme 2 in lung diseases","volume":"6","author":"Kuba","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.mce.2021.111263_bib19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.mce.2021.111263_bib20","doi-asserted-by":"crossref","first-page":"30113","DOI":"10.1074\/jbc.M505111200","article-title":"Tumor necrosis factor-\u03b1 convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)","volume":"280","author":"Lambert","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2021.111263_bib21","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00239.2008","article-title":"High glucose-induced Nox1-derived superoxides downregulate PKC-\u03b2II, which subsequently decreases ACE2 expression and ANG(1-7) formation in rat VSMCs","volume":"296","author":"Lavrentyev","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.mce.2021.111263_bib22","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/path.1670","article-title":"Renal ACE2 expression in human kidney disease","volume":"204","author":"Lely","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.mce.2021.111263_bib23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.mce.2021.111263_bib24","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.mce.2021.111263_bib25","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/S2213-2600(20)30224-1","article-title":"SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors","volume":"8","author":"Milne","year":"2020","journal-title":"Lancet Respir. Med"},{"key":"10.1016\/j.mce.2021.111263_bib26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1053\/j.ajkd.2007.11.022","article-title":"Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls","volume":"51","author":"Mizuiri","year":"2008","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.mce.2021.111263_bib27","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.mce.2021.111263_bib28","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.2337\/dbi20-0019","article-title":"SARS-CoV-2 infections and ACE2: clinical outcomes linked with increased morbidity and mortality in individuals with diabetes","volume":"69","author":"Obukhov","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2021.111263_bib29","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/01.HYP.0000237862.94083.45","article-title":"Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat","volume":"48","author":"Ocaranza","year":"2006","journal-title":"Hypertension (Dallas)"},{"key":"10.1016\/j.mce.2021.111263_bib30","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2362.2009.02153.x","article-title":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS","volume":"39","author":"Oudit","year":"2009","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.mce.2021.111263_bib31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2337\/db09-1218","article-title":"Human recombinant ACE2 reduces the progression of diabetic nephropathy","volume":"59","author":"Oudit","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2021.111263_bib32","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/ndt\/gfaa093","article-title":"ADAM17 inhibition may exert a protective effect on COVID-19","volume":"35","author":"Palau","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.mce.2021.111263_bib33","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1161\/CIRCRESAHA.112.268029","article-title":"Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II\/AT1 receptor axis","volume":"110","author":"Patel","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.mce.2021.111263_bib34","first-page":"97","article-title":"Ibuprofen attenuates cardiac fibrosis in streptozotocin-induced diabetic rats","volume":"131","author":"Qiao","year":"2015","journal-title":"Cardiol."},{"key":"10.1016\/j.mce.2021.111263_bib35","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/ki.2008.497","article-title":"Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease","volume":"74","author":"Reich","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.mce.2021.111263_bib36","doi-asserted-by":"crossref","first-page":"F534","DOI":"10.1152\/ajprenal.00082.2015","article-title":"Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria","volume":"310","author":"Riera","year":"2016","journal-title":"Am. J. Physiol. Physiol."},{"key":"10.1016\/j.mce.2021.111263_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18030563","article-title":"Characterization of ACE and ACE2 expression within different organs of the NOD mouse","volume":"18","author":"Roca-Ho","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.mce.2021.111263_bib38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nrendo.2015.6","article-title":"Novel RAAS agonists and antagonists: clinical applications and controversies","volume":"11","author":"Romero","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.mce.2021.111263_bib39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/HYPERTENSIONAHA.119.14071","article-title":"Ang II (angiotensin II) conversion to angiotensin-(1-7) in the circulation is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting enzyme 2)-independent","volume":"75","author":"Serfozo","year":"2020","journal-title":"Hypertension (Dallas)"},{"key":"10.1016\/j.mce.2021.111263_bib40","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s00380-016-0936-5","article-title":"The effect of fluvastatin on cardiac fibrosis and angiotensin-converting enzyme-2 expression in glucose-controlled diabetic rat hearts","volume":"32","author":"Shin","year":"2017","journal-title":"Heart Ves."},{"key":"10.1016\/j.mce.2021.111263_bib41","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.90488.2008","article-title":"Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan","volume":"296","author":"Soler","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.mce.2021.111263_bib42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/HJH.0b013e32834f04b6","article-title":"Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications","volume":"30","author":"Soro-Paavonen","year":"2012","journal-title":"J. Hypertens."},{"key":"10.1016\/j.mce.2021.111263_bib43","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41581-020-0279-4","article-title":"Controversies of renin\u2013angiotensin system inhibition during the COVID-19 pandemic","volume":"16","author":"South","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"issue":"5","key":"10.1016\/j.mce.2021.111263_bib44","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2215\/CJN.03530320","article-title":"Sound science before quick judgement regarding RAS blockade in COVID-19","volume":"15","author":"Sparks","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"107628","key":"10.1016\/j.mce.2021.111263_bib45","article-title":"Good or bad: application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities","volume":"215","author":"Wang","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.mce.2021.111263_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2521-4","article-title":"OpenSAFELY: factors associated with COVID-19 death in 17 million patients","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.mce.2021.111263_bib47","first-page":"1","article-title":"Advances in research on ACE2 as a receptor for 2019-nCoV","volume":"1","author":"Wu","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.mce.2021.111263_bib48","doi-asserted-by":"crossref","first-page":"F600","DOI":"10.1152\/ajprenal.00600.2012","article-title":"Regulation of urinary ACE2 in diabetic mice","volume":"305","author":"Wysocki","year":"2013","journal-title":"Am. J. Physiol. Physiol."},{"issue":"9","key":"10.1016\/j.mce.2021.111263_bib49","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1681\/ASN.2020050667","article-title":"Kidney and lung ACE2 expression after an ACE inhibitor or an ang II receptor blocker: implications for COVID-19","volume":"31","author":"Wysocki","year":"2020","journal-title":"J. Am. Soc. Nephrol. ASN."},{"issue":"4","key":"10.1016\/j.mce.2021.111263_bib50","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1681\/ASN.2020101537","article-title":"A novel soluble ACE2 variant with prolonged duration of action neutralizes SARS-CoV-2 infection in human kidney organoids","volume":"32","author":"Wysocki","year":"2021","journal-title":"J. Am. Soc. Nephrol. ASN."},{"key":"10.1016\/j.mce.2021.111263_bib51","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.2337\/db06-0033","article-title":"ACE and ACE2 activity in diabetic mice","volume":"55","author":"Wysocki","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2021.111263_bib52","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1038\/srep07027","article-title":"Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury","volume":"4","author":"Yang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mce.2021.111263_bib53","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1161\/01.HYP.0000126192.27644.76","article-title":"Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination?","volume":"43","author":"Ye","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2021.111263_bib54","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1681\/ASN.2006050423","article-title":"Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes","volume":"17","author":"Ye","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.mce.2021.111263_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2019.104350","article-title":"ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway","volume":"113","author":"Ye","year":"2020","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.mce.2021.111263_bib56","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.110.955369","article-title":"Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction","volume":"122","author":"Zhong","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2021.111263_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720721001076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720721001076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:16:36Z","timestamp":1759587396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720721001076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":57,"alternative-id":["S0303720721001076"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2021.111263","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of ramipril on kidney, lung and heart ACE2 in a diabetic mice model","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2021.111263","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111263"}}